Announcement on Passing On-site Inspection by FDA
Filed with SSE · · 2 pages · Chinese
Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Starry Pharmaceutical
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Announcement on the Completion of Negotiated Transfer Registration for Partial Shares Held by the Controlling Shareholder and Actual Controller
Later from Zhejiang Starry Pharmaceutical
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Announcement on Circulation of Restricted Shares Issued to Specific Objects
- Annual Earnings Preannouncement for 2024
- Announcement on Resolutions of the 12th Meeting of the 5th Board of Supervisors
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Business License
Follow Zhejiang Starry Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Starry Pharmaceutical